A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully(University College London Hospitals NHS Foundation Trust), Samuel J. Machin(University College London), Beverley J. Hunt, Ian Longair(University College Hospital), Vickie McDonald(University College London), Hannah Cohen(University College Hospital), Jamie Cavenagh(St Bartholomew's Hospital)
Cited by 420
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
The “Primary” Antiphospholipid Syndrome
|Medicine|1989|963
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
|British Journal of Haematology|2012|861
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis
|European Journal of Vascular and Endovascular Surgery|2020|709